Using Digital Health, Financial Incentives, and Community Health Worker Support to Change Health Behavior
Combining Best Practices for Health Behavior Change: a Randomized Controlled Trial of Digital Health, Financial Incentives and Community Health Worker Support for Vulnerable Populations
1 other identifier
interventional
150
1 country
1
Brief Summary
This randomized controlled trial tests how digital health monitoring with financial incentives (DFI) and community health worker (CHW) support may affect how a person manages their diabetes. Participants will be randomized to one of three arms: 1) DFI intervention, 2) hybrid DFI/CHW intervention, or 3) usual care. Investigators hypothesize that compared to usual care and DFI alone, the hybrid intervention will lead to more glucose self-monitoring and greater improvements in glycosylated hemoglobin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes-mellitus
Started May 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2019
CompletedFirst Posted
Study publicly available on registry
May 7, 2019
CompletedStudy Start
First participant enrolled
May 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 28, 2020
CompletedResults Posted
Study results publicly available
September 5, 2024
CompletedSeptember 5, 2024
August 1, 2024
1.2 years
May 3, 2019
September 21, 2023
August 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glucose Self-monitoring Adherence
constructed by summing the number of days in the study period that the glucometer was used divided by the total number of days in study period
3 months
Other Outcomes (1)
Change in Glycosylated Hemoglobin
6 months
Study Arms (3)
Usual Clinical Support
PLACEBO COMPARATORParticipants will continue with their usual diabetes care provided by their clinic. Participants will receive a free wireless glucometer on the day of enrollment if they do not already have one.
DFI Alone
ACTIVE COMPARATORParticipants will receive a free wireless glucometer on the day of enrollment if they don't already have one. To encourage habit formation, for the first 6 weeks of the trial, participants will be eligible for a daily lottery incentive for every day that they use their glucometer. Investigators will use an approach similar to what we have used in prior DFI trials: the lottery will provide infrequent large payoffs (a 1 in 100 chance of a US$50 reward) and more frequent small payoffs (an 18 in 100 chance of a US $5 reward). Participants who draw the winning lottery number, but did not check their glucose the day prior will receive an automated text or e-mail message informing them what earnings they would have won had they used their glucometer. After 6 weeks, investigators will terminate the lottery but continue to monitor patients' adherence to glucose self-monitoring.
Hybrid DFI CHW
EXPERIMENTALParticipants in the hybrid intervention will receive a wireless glucometer if they don't already have one and financial incentives just as in the DFI intervention. However, any individuals who have low adherence (no self-monitoring) or elevated glucose readings (\>300 mg/dL) for \>30% of days over any 2 week period in the first 12 weeks of the study will be assigned to receive ongoing community health worker (CHW) support for the duration of the 24-week study period.
Interventions
Once a CHW receives notification of a struggling patient, the CHW will visit the patient at their home within 1-2 days to initiate the IMPaCT intervention. 1. Elements of the standard IMPaCT intervention: During the first home visit, the CHW will use an in-depth semi-structured interview guide to get to know patients holistically and assess for unmet socioeconomic needs. This allows patients to express goals in line with their own needs and preferences. These individualized goals will become the basis for tailored action plans. The CHW will then provide hands-on, tailored support for the remainder of the 24-week study period to help patients achieve their goals. 2. Additional elements to help patients cope with failure: In this study, we will test a refined version of IMPaCT that incorporates two behavioral techniques for coping with failure: positive affect induction and attribution retraining.
Participants are encouraged to use their glucometer to check their blood glucose via bidirectional texting and lottery-based financial incentives, which both serve to reinforce self-monitoring behavior.
Eligibility Criteria
You may qualify if:
- Penn Medicine patients diagnosed with diabetes mellitus.
- Glycosylated hemoglobin \>=9% within the past 6 months.
- Requires insulin.
- Uninsured/publicly insured.
- Residents of high-poverty ZIP codes in West/Southwest Philadelphia.
- Have access to a cellphone with unlimited text message capabilities.
You may not qualify if:
- Already have a continuous glucose monitor.
- Previously enrolled in the study.
- Currently have an outpatient CHW.
- Unwilling/unable to provide informed consent.
- In another study that asks participants to monitor their blood sugar.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pennsylvanialead
- The Commonwealth Fundcollaborator
Study Sites (1)
Penn Medicine
Philadelphia, Pennsylvania, 19104, United States
Related Publications (1)
Whitehouse CR, Knowles M, Long JA, Mitra N, Volpp KG, Xu C, Sabini C, Gerald N, Estrada I, Jones D, Kangovi S. Digital Health and Community Health Worker Support for Diabetes Management: a Randomized Controlled Trial. J Gen Intern Med. 2023 Jan;38(1):131-137. doi: 10.1007/s11606-022-07639-6. Epub 2022 May 17.
PMID: 35581452DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
The COVID pandemic may have led to a higher-than-expected rate of loss to follow-up at 6 months. A COVID-19 modification truncated our primary outcome from 6 to 3 months. Unlike many DHI requiring smartphones, we only required participants to have a basic cell phone; participants needed to text their SMBG to the study platform which may have increased attrition. Because we used low-tech glucometers covered by Medicaid, we extracted data from the physical device, resulting in some missing data.
Results Point of Contact
- Title
- Director of Evaluation
- Organization
- Penn Center for Community Health Workers
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 3, 2019
First Posted
May 7, 2019
Study Start
May 15, 2019
Primary Completion
July 28, 2020
Study Completion
July 28, 2020
Last Updated
September 5, 2024
Results First Posted
September 5, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share